The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to ...

The selective estrogen receptor degrader giredestrant plus palbociclib (Ibrance) did not significantly improve progression-free survival (PFS) in advanced hormone receptor-positive/HER2-negative ...

The study will assess the tolerability, safety, maximum tolerated dose, and the recommended Phase II dose of PLT012.

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...

Some animal facts sound like they were invented for shock value, but then you check the research and realize they are ...

CD4+ T cells, long regarded as supporting actors in cancer immunity, are emerging as central regulators of tumor control and ...

Japan approves world-first iPS cell therapies for heart failure, Parkinsons Conditional approvals speed Japans first iPS treatments into clinics for heart failure and Parkinsons ...

Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody ...

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain. During development, all the specialized neurons in the ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune ...